Standard

Selenium, selenoprotein P, and Alzheimer's disease: Is there a link? / Solovyev, Nikolay; Drobyshev, Evgenii; Bjørklund, Geir; Dubrovskii, Yaroslav; Lysiuk, Roman; Rayman, Margaret P.

In: Free Radical Biology and Medicine, Vol. 127, 2018, p. 124-133.

Research output: Contribution to journalReview articlepeer-review

Harvard

Solovyev, N, Drobyshev, E, Bjørklund, G, Dubrovskii, Y, Lysiuk, R & Rayman, MP 2018, 'Selenium, selenoprotein P, and Alzheimer's disease: Is there a link?', Free Radical Biology and Medicine, vol. 127, pp. 124-133. https://doi.org/10.1016/j.freeradbiomed.2018.02.030

APA

Vancouver

Author

Solovyev, Nikolay ; Drobyshev, Evgenii ; Bjørklund, Geir ; Dubrovskii, Yaroslav ; Lysiuk, Roman ; Rayman, Margaret P. / Selenium, selenoprotein P, and Alzheimer's disease: Is there a link?. In: Free Radical Biology and Medicine. 2018 ; Vol. 127. pp. 124-133.

BibTeX

@article{8decf1fb2f37492a965ce66e7743e953,
title = "Selenium, selenoprotein P, and Alzheimer's disease: Is there a link?",
abstract = "The essential trace element, selenium (Se), is crucial to the brain but it may be potentially neurotoxic, depending on dosage and speciation; Se has been discussed for decades in relation to Alzheimer's disease (AD). Selenoprotein P (SELENOP) is a secreted heparin-binding glycoprotein which serves as the main Se transport protein in mammals. In vivo studies showed that this protein might have additional functions such as a contribution to redox regulation. The current review focuses on recent research on the possible role of SELENOP in AD pathology, based on model and human studies. The review also briefly summarizes results of epidemiological studies on Se supplementation in relation to brain diseases, including PREADViSE, EVA, and AIBL. Although mainly positive effects of Se are assessed in this review, possible detrimental effects of Se supplementation or exposure, including potential neurotoxicity, are also mentioned. In relation to AD, various roles of SELENOP are discussed, i.e. as the means of Se delivery to neurons, as an antioxidant, in cytoskeleton assembly, in interaction with redox-active metals (copper, iron, and mercury) and with misfolded proteins (amyloid-beta and hyperphosphorylated tau-protein).",
keywords = "Alzheimer's disease, Amyloid-beta, Brain, Human studies, Model studies, Neurodegeneration, Oxidative stress, Redox regulation, Selenium, Selenoprotein P, Supplementation, Trace elements, OXIDATIVE STRESS, PROGRESSIVE CEREBELLOCEREBRAL ATROPHY, PROSTATE-CANCER PREVENTION, HUMAN HEALTH, CEREBROSPINAL-FLUID, LATERAL-SCLEROSIS PATIENTS, COGNITIVE DECLINE, SEVERE NEUROLOGICAL DYSFUNCTION, A-BETA, APOLIPOPROTEIN-E RECEPTOR-2",
author = "Nikolay Solovyev and Evgenii Drobyshev and Geir Bj{\o}rklund and Yaroslav Dubrovskii and Roman Lysiuk and Rayman, {Margaret P.}",
year = "2018",
doi = "10.1016/j.freeradbiomed.2018.02.030",
language = "English",
volume = "127",
pages = "124--133",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Selenium, selenoprotein P, and Alzheimer's disease: Is there a link?

AU - Solovyev, Nikolay

AU - Drobyshev, Evgenii

AU - Bjørklund, Geir

AU - Dubrovskii, Yaroslav

AU - Lysiuk, Roman

AU - Rayman, Margaret P.

PY - 2018

Y1 - 2018

N2 - The essential trace element, selenium (Se), is crucial to the brain but it may be potentially neurotoxic, depending on dosage and speciation; Se has been discussed for decades in relation to Alzheimer's disease (AD). Selenoprotein P (SELENOP) is a secreted heparin-binding glycoprotein which serves as the main Se transport protein in mammals. In vivo studies showed that this protein might have additional functions such as a contribution to redox regulation. The current review focuses on recent research on the possible role of SELENOP in AD pathology, based on model and human studies. The review also briefly summarizes results of epidemiological studies on Se supplementation in relation to brain diseases, including PREADViSE, EVA, and AIBL. Although mainly positive effects of Se are assessed in this review, possible detrimental effects of Se supplementation or exposure, including potential neurotoxicity, are also mentioned. In relation to AD, various roles of SELENOP are discussed, i.e. as the means of Se delivery to neurons, as an antioxidant, in cytoskeleton assembly, in interaction with redox-active metals (copper, iron, and mercury) and with misfolded proteins (amyloid-beta and hyperphosphorylated tau-protein).

AB - The essential trace element, selenium (Se), is crucial to the brain but it may be potentially neurotoxic, depending on dosage and speciation; Se has been discussed for decades in relation to Alzheimer's disease (AD). Selenoprotein P (SELENOP) is a secreted heparin-binding glycoprotein which serves as the main Se transport protein in mammals. In vivo studies showed that this protein might have additional functions such as a contribution to redox regulation. The current review focuses on recent research on the possible role of SELENOP in AD pathology, based on model and human studies. The review also briefly summarizes results of epidemiological studies on Se supplementation in relation to brain diseases, including PREADViSE, EVA, and AIBL. Although mainly positive effects of Se are assessed in this review, possible detrimental effects of Se supplementation or exposure, including potential neurotoxicity, are also mentioned. In relation to AD, various roles of SELENOP are discussed, i.e. as the means of Se delivery to neurons, as an antioxidant, in cytoskeleton assembly, in interaction with redox-active metals (copper, iron, and mercury) and with misfolded proteins (amyloid-beta and hyperphosphorylated tau-protein).

KW - Alzheimer's disease

KW - Amyloid-beta

KW - Brain

KW - Human studies

KW - Model studies

KW - Neurodegeneration

KW - Oxidative stress

KW - Redox regulation

KW - Selenium

KW - Selenoprotein P

KW - Supplementation

KW - Trace elements

KW - OXIDATIVE STRESS

KW - PROGRESSIVE CEREBELLOCEREBRAL ATROPHY

KW - PROSTATE-CANCER PREVENTION

KW - HUMAN HEALTH

KW - CEREBROSPINAL-FLUID

KW - LATERAL-SCLEROSIS PATIENTS

KW - COGNITIVE DECLINE

KW - SEVERE NEUROLOGICAL DYSFUNCTION

KW - A-BETA

KW - APOLIPOPROTEIN-E RECEPTOR-2

UR - http://www.scopus.com/inward/record.url?scp=85043307970&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2018.02.030

DO - 10.1016/j.freeradbiomed.2018.02.030

M3 - Review article

AN - SCOPUS:85043307970

VL - 127

SP - 124

EP - 133

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

ER -

ID: 23855914